BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Yatharth Hospital & Trauma Care Services Ltd. Share Price

NSE
BSE

NSE : YATHARTH

BSE : 543950

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹1,112.90

High

₹1,147.50

Price Summary

Previous Close ₹1,125.30
Day's Range ₹1,112.90 - ₹1,147.50
Open ₹1,139.50
52 Week Range ₹538.25 - ₹1,184.00
Volume 5,58,832
Market Cap ₹0.01
Previous Close ₹1,123.25
Day's Range ₹1,112.15 - ₹1,148.70
Open ₹1,148.70
52 Week Range ₹538.15 - ₹1,183.15
Volume 46,815
Market Cap ₹0.01

Stocks Summary

Trade Value ( ₹ in Lacs) 6,298.31
Market Cap (₹ in Mn) 0.01
Dividend Yield(%) 0.00
Price/Earning (TTM) 59.74
TTM EPS (₹) 18.80
P/E Ratio 33.91
Book Value(₹) 5.93
PAT Margin (%) 14.11
Face Value (₹) 10.00
ROCE(%) 13.30
Trade Value ( ₹ in Lacs) 527.98
Market Cap (₹ in Mn) 0.01
Dividend Yield(%) 0.00
Price/Earning (TTM) 59.74
TTM EPS (₹) 18.80
P/E Ratio 33.91
Book Value(₹) 5.93
PAT Margin (%) 14.11
Face Value (₹) 10.00
ROCE(%) 13.30

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 2592.47 4564.84
Expenses N/A N/A
PBT 586.88 1194.31
Operating profit 0.0 0.0
Net profit 420.4 876.92

Shareholding Pattern

Promoters (% Holding)

55.80%

Mutual funds (% Holding)

9.74%

Non-Institution (% Holding)

27.74%

FI/Banks/Insurance (% Holding)

0.36%

Government (% Holding)

0.00%

FII

5.62%

About Yatharth Hospital & Trauma Care Services Ltd.

Founded 2008
Managing Director Kapil Kumar
NSE Symbol YATHARTH

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,48,195.77 1,868.00 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 2,50,389.96 9,432.00 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,88,966.75 4,968.00 3,480.60 - 3,480.60
Apollo Hospitals Enterprise Ltd. 1,28,543.48 8,940.00 6,696.50 - 6,696.50
Lenskart Solutions Ltd. 1,18,933.76 685.00 0.00 - 0.00
Zydus Lifesciences Ltd. 1,15,860.07 1,161.50 835.50 - 835.50
Cipla Ltd. 1,11,888.39 1,385.00 1,165.70 - 1,165.70
Laurus Labs Ltd. 1,09,035.01 2,018.00 823.10 - 823.10
Max Healthcare Institute Ltd. 1,03,608.88 1,064.50 903.00 - 903.00
Mankind Pharma Ltd. 1,00,363.76 2,429.85 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Sep
17
2026
EQUITY Posted on Sep 17th 2026

Yatharth Hospital & Trauma Care Services informs about press release

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Yatharth Hospital & Trauma Care Services has informed that it enclosed the Press Release. The above Press Release will also be made available on the Company’s website: https://www.yatharthhospitals.com/investors/corporate-announcements. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
17
2026
EQUITY Posted on Sep 17th 2026

Yatharth Hospital & Trauma Care Services informs about outcome of board meeting

Yatharth Hospital & Trauma Care Services has informed that the Board of Directors (Board) of Yatharth Hospital & Trauma Care Services at their meeting held today, September 17, 2026 has considered and approved the following- the increase in the authorised share capital of the Company from INR 115,00,00,000 (Indian Rupees One Hundred Fifteen Crores) divided into 11,50,00,000 (Eleven Crore Fifty Lakhs) equity shares of face value of INR 10 (Indian Rupees Ten) each, to INR 150,00,00,000 (Indian Rupees One Hundred Fifty Crores) divided into 15,00,00,000 (Fifteen Crores) equity shares of face value of INR 10 (Indian Rupees Ten) each; Issuance and allotment of equity shares and warrants of the Company by way of preferential issue on a private placement basis.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
11
2026
EQUITY Posted on Aug 11th 2026

Yatharth Hospital & Trauma Care Services informs about investors presentation

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Yatharth Hospital & Trauma Care Services has informed that it enclosed the Investor’s Presentation on financial results of the Company for the Q1FY27. The above presentation will also be made available on website of the Company at https://www.yatharthhospitals.com/investors/corporate-announcements.

The above information is a part of company’s filings submitted to BSE.  

Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

Haleos Labs informs about closure of trading window

Haleos Labs has informed that ‘Trading Window’ for dealing in securities of the Company for Designated Persons and specified Connected Persons (including their Immediate relatives) of the Company and Subsidiary of the Company, shall remain closed with effect from October 1, 2026 till 48 hours after the declaration of financial results for quarter and half year ended sept 30, 2026, In terms of the ‘Code of Conduct for Prevention of Insider Trading’ of the Company. Date of the Board meeting for considering the unaudited financial results Of the Company for the quarter and half year ended September 30, 2026, will be informed separately in due course. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

Cohance Lifesciences informs about update

Cohance Lifesciences has informed that the United States Food and Drug Administration (USFDA) inspected the Company’s API manufacturing facility at Jaggaiahpet, Andhra Pradesh, India (FEI No. 3005554260), from 14 September to 19 September 2026. The inspection concluded with the issuance of a Form FDA 483 containing five observations. The Company has initiated appropriate corrective and preventive actions (CAPA) and will submit its response within the stipulated timeline. The Company remains committed to quality and regulatory compliance.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Yatharth Hospital & Trauma Care Services Ltd. ?

The current share price of Yatharth Hospital & Trauma Care Services Ltd. is ₹1,125.30 as of 2026-09-21.

The market capitalisation of Yatharth Hospital & Trauma Care Services Ltd. is ₹10,823.00 as of 2026-09-21.

The 1-year return of Yatharth Hospital & Trauma Care Services Ltd. is 348.85% as of 2026-09-21.

The P/E ratio of Yatharth Hospital & Trauma Care Services Ltd. is 33.91 as of 2026-09-22.

The 52-week high and low of Yatharth Hospital & Trauma Care Services Ltd. are ₹1,184.00 and ₹538.25, respectively, as of 2026-09-21.

The dividend yield of Yatharth Hospital & Trauma Care Services Ltd. is 0.0% as of2026-09-21.

You can buy Yatharth Hospital & Trauma Care Services Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Yatharth Hospital & Trauma Care Services Ltd. is Kapil Kumar.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

People Also Ask

How does Yatharth Hospital & Trauma Care Services Ltd. collaborate with pharmaceutical firms and other healthcare entities?

Yatharth Hospital & Trauma Care Services Ltd. collaborates with pharmaceutical companies and other healthcare entities through clinical practices, procurement of medical equipment, and integration of healthcare technologies. Its hospitals may also serve as clinical settings for treatment protocols and the use of advanced medical devices, while partnering with suppliers to maintain modern healthcare infrastructure.

Yatharth Hospital & Trauma Care Services Ltd. operates multi-specialty hospitals, primarily located in the National Capital Region (NCR). Its facilities provide a range of healthcare services, including trauma care, cardiology, orthopedics, and critical care, supported by intensive care units and related medical infrastructure.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore